نتایج جستجو برای: hydrochloric acid37 merck
تعداد نتایج: 13329 فیلتر نتایج به سال:
Disclosure of potential conflict of interest: L. Cox is a consultant for Genentech/Novartis, Hollister-Stier, and Stallergenes; is a speaker for Novartis; has received research support from Stallergenes; is on the Board of Directors for the American Board of Allergy and Immunology; and is on the US Food and Drug Administration (FDA)’s Allergenic Product Advisory Committee. H. Nelson is a consul...
Next-generation sequencing (NGS) is quickly replacing other methods for determining expression profiling of RNA as well as single-nucleotide variations within the genomes of both model organisms and human samples. At the Boston facility of Merck Research Laboratories, we concentrate on preparation and sequencing of samples where the research needs cannot be met by commercial venders. These unme...
formation was published in an erratum in the February issue of the Journal [2]. This is an obvious error, because the study, funded by Merck & Co., used the Merck & Co. product RECOMBIVAX HB/H-B-VaxII. The Discussion section discussed only the use of RECOMBIVAX HB/H-B-VaxII as a 2-dose regimen. It was not our intent to suggest that the Twinrix product did not stimulate a good immunologic respon...
Dr Meltzer has received grant/research support from Alcon, Alexza Pharmaceuticals, Amgen, Antigen Labs, Apotex, Astellas, AstraZeneca, Boehringer Ingelheim, Forest, GlaxoSmithKline, Johnson & Johnson, MAP, MEDA, Medimmune, Merck, Novartis, Proctor & Gamble, Schering-Plough, Sepracor, Teva, and UCB. He has served as a consultant/speaker for Alcon, Alexza Pharmaceuticals, Amgen, AstraZeneca, Boeh...
Background. ISENTRESS (raltegravir, RAL) is licensed for 400 mg b.i.d. use. An investigational 1200 mg q.d. regimen for reformulated raltegravir (re-RAL) is under clinical development. This study assessed the safety and pharmacokinetics (PK) of a higher dose of re-RAL. Methods. A double-blind, multiple-dose, randomized, fully domiciled study assessed the safety and PK of 1800 mg dose of re-RAL ...
Cross-linked chitosan was synthesized with chitosan and ethylene glycol diglycidyl ether. The adsorption behavior of trace amounts of metal ions on the cross-linked chitosan was systematically examined by packing it in a mini-column, passing a metal solution through it and measuring metal ions in the effluent by ICP-MS. The cross-linked chitosan adsorbed mercury and precious metals (Pd, Pt, and...
Department of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Rosetta Inpharmatics, LLC, Merck & Co., Inc., Seattle, WA 98109; Quellos High Throughput Screening Core, Department of Pharmacology, Institute for Stem Cells and Regenerative Medicine and Seattle Children’s Hospital and Department of Pediatrics, University of Washington, Seattle, WA 98109; and Merck & Co., W...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید